Glaukos Corp. (GKOS)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Glaukos Corp. (GKOS)
Go deeper and ask any question about GKOS
Company Performance
Current Price
as of Sep 18, 2024$122.31
P/E Ratio
N/A
Market Cap
$6.72B
Description
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Metrics
Overview
- HQAliso Viejo, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerGKOS
- Price$122.31+0.60%
Trading Information
- Market Cap$6.72B
- Float96.38%
- Average Daily Volume (1m)518,204
- Average Daily Volume (3m)578,703
- EPS-$3.20
Company
- Revenue$341.73M
- Rev Growth (1yr)19.02%
- Net Income-$50.54M
- Gross Margin76.43%
- EBITDA Margin-20.43%
- EBITDA-$19.55M
- EV$5.90B
- EV/Revenue17.26
- P/EN/A
- P/S18.15
Documents
SEC Filings
Earnings Calls
Factset Street Account